Drug-resistant | South African leads research

South African TB research is influencing global policy changes for the treatment of drug-resistant variants. The World Health Organisation has announced key changes, with treatment time slashed from 18 to 6 months. eNCA’s Morena Mothupi speaks to Norbert Ndjeka, the Director of drug-resistant TB from the Health Department. Courtesy #DStv403